<VariationArchive RecordType="classified" VariationID="562389" VariationName="NM_001018113.3(FANCB):c.1668del (p.Asp557fs)" VariationType="Deletion" Accession="VCV000562389" Version="5" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2023-10-07" DateCreated="2018-10-01" MostRecentSubmission="2023-09-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="553573" VariationID="562389">
      <GeneList>
        <Gene Symbol="FANCB" FullName="FA complementation group B" GeneID="2187" HGNC_ID="HGNC:3583" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="14689524" stop="14873069" display_start="14689524" display_stop="14873069" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="14861528" stop="14891183" display_start="14861528" display_stop="14891183" Strand="-" />
          </Location>
          <OMIM>300515</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FANCB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FANCB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001018113.3(FANCB):c.1668del (p.Asp557fs)</Name>
      <CanonicalSPDI>NC_000023.11:14845114:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="14845115" stop="14845115" display_start="14845115" display_stop="14845115" variantLength="1" positionVCF="14845114" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="14863237" stop="14863237" display_start="14863237" display_stop="14863237" variantLength="1" positionVCF="14863236" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D557fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_496" sequenceAccession="LRG_496">
            <Expression>LRG_496:g.32948del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_496t1" sequenceAccession="LRG_496t1">
            <Expression>LRG_496t1:c.1668del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018113.3" sequenceAccession="NM_001018113" sequenceVersion="3" change="c.1668delT" MANESelect="true">
            <Expression>NM_001018113.3:c.1668delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018113.1" sequenceAccession="NM_001018113" sequenceVersion="1" change="c.1668del">
            <Expression>NM_001018113.1:c.1668del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.14863237del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.14863237del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.14845115del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.14845115del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007310.1" sequenceAccession="NG_007310" sequenceVersion="1" change="g.32948del">
            <Expression>NG_007310.1:g.32948del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018113.3" sequenceAccession="NM_001018113" sequenceVersion="3" change="c.1668del" MANESelect="true">
            <Expression>NM_001018113.3:c.1668del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018123.1" sequenceAccession="NP_001018123" sequenceVersion="1" change="p.Asp557fs">
            <Expression>NP_001018123.1:p.Asp557fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001324162.2" sequenceAccession="NM_001324162" sequenceVersion="2" change="c.1668del">
            <Expression>NM_001324162.2:c.1668del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001311091.1" sequenceAccession="NP_001311091" sequenceVersion="1" change="p.Asp557fs">
            <Expression>NP_001311091.1:p.Asp557fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152633.4" sequenceAccession="NM_152633" sequenceVersion="4" change="c.1668del">
            <Expression>NM_152633.4:c.1668del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689846.1" sequenceAccession="NP_689846" sequenceVersion="1" change="p.Asp557fs">
            <Expression>NP_689846.1:p.Asp557fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300515.0003" DB="OMIM" />
        <XRef Type="rs" ID="1569083679" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001018113.3(FANCB):c.1668del (p.Asp557fs) AND not provided" Accession="RCV000681853" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001018113.3(FANCB):c.1668del (p.Asp557fs) AND Fanconi anemia complementation group B" Accession="RCV000851562" Version="3">
        <ClassifiedConditionList TraitSetID="3035">
          <ClassifiedCondition DB="MedGen" ID="C1845292">Fanconi anemia complementation group B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-19" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-10-19" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-10-01" MostRecentSubmission="2023-09-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15502827</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17924555</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3035" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1275" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FANCONI PANCYTOPENIA, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group B</ElementValue>
                <XRef ID="MONDO:0010351" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FACB</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FA2</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FANCB</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FANCB-Related Fanconi Anemia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C1845292" DB="MedGen" />
              <XRef ID="MONDO:0010351" DB="MONDO" />
              <XRef Type="MIM" ID="300514" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31847" SubmissionDate="2012-09-07" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300515.0003_FANCONI ANEMIA, COMPLEMENTATION GROUP B" title="FANCB, 1-BP DEL, 1650T_FANCONI ANEMIA, COMPLEMENTATION GROUP B" />
        <ClinVarAccession Accession="SCV000031847" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an individual considered a candidate for group B Fanconi anemia (300514) on the basis of exclusion from most of the other complementation groups, inability to monoubiquitinate FANCD2, and male gender, Meetei et al. (2004) found a frameshift mutation, 1650delT, in exon 8 of the FANCB gene.</Attribute>
              <Citation>
                <ID Source="PubMed">15502827</ID>
              </Citation>
              <XRef DB="OMIM" ID="300514" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCB" />
          </GeneList>
          <Name>FANCB, 1-BP DEL, 1650T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1650T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300515.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1578232" SubmissionDate="2018-09-24" DateLastUpdated="2018-10-01" DateCreated="2018-10-01">
        <ClinVarSubmissionID localKey="GHARVar218|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000809331" DateUpdated="2018-10-01" DateCreated="2018-10-01" Type="SCV" Version="1" SubmitterName="Gharavi Laboratory, Columbia University" OrgID="506730" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" alternateAllele="C" referenceAllele="CA" start="14863236" stop="14863237" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4556013</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1949395" SubmissionDate="2020-02-28" DateLastUpdated="2020-07-25" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="FANCB_000002|OMIM:300514" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000994636" DateUpdated="2020-07-25" DateCreated="2019-09-29" Type="SCV" Version="2" SubmitterName="Leiden Open Variation Database" OrgID="506264" OrganizationCategory="other" OrgAbbreviation="LOVD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15502827</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17924555</ID>
          </Citation>
          <Comment>Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Johan de Winter.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001018113.1:c.1668del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.14863237_14863237del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300514" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7063195</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7555831" SubmissionDate="2023-08-31" DateLastUpdated="2023-09-30" DateCreated="2023-09-30">
        <ClinVarSubmissionID localKey="chrX:14863237" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004037366" DateUpdated="2023-09-30" DateCreated="2023-09-30" Type="SCV" Version="1" SubmitterName="Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center" OrgID="508215" OrganizationCategory="laboratory" OrgAbbreviation="PGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15502827</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17924555</ID>
          </Citation>
          <Comment>The c.1668delT variant is a heterozygous single-base deletion in exon 8 (out of 10 exons) of the FANCB (NM_001018113.3) gene. It causes a frameshift at amino acid position 557, changing aspartic acid at this position to isoleucine and resulting in a premature stop codon 21 residues downstream (p.Asp557Ilefs*21). This variant is predicted to cause loss-of-function of the protein by nonsense mediated mRNA decay. It is absent in the Genome Aggregation Database (gnomAD), indicating that it is not a common benign variant in the populations represented therein. This variant in hemizygous state has been previously reported as 1650delT in a male patient with Fanconi anemia complementation group B (PMID: 15502827 and 17924555). It has also been reported in the ClinVar database as pathogenic by two submitters (Variation ID: 562389, last accessed 10/19/2020). Based on these reasons, it is classified here as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Hispanic American</Ethnicity>
              <GeographicOrigin>Mexico</GeographicOrigin>
              <Tissue>peripheral blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">40</Age>
              <Age Type="maximum" age_unit="years">49</Age>
              <AffectedStatus>no</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <FamilyData>
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <Purpose>validation</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0032316" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001018113.3:c.1668delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300514" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808666</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7555831" TraitType="Finding" MappingType="XRef" MappingValue="HP:0032316" MappingRef="HP">
        <MedGen CUI="C0241889" Name="Family history" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7555831" TraitType="Disease" MappingType="XRef" MappingValue="300514" MappingRef="OMIM">
        <MedGen CUI="C1845292" Name="Fanconi anemia complementation group B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="31847" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP B" MappingRef="Preferred">
        <MedGen CUI="C1845292" Name="Fanconi anemia complementation group B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1578232" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1949395" TraitType="Disease" MappingType="XRef" MappingValue="300514" MappingRef="OMIM">
        <MedGen CUI="C1845292" Name="Fanconi anemia complementation group B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

